Efficacy of Spironolactone in Cameroonian Diabetic Patients With Resistant Hypertension

Clinical trial NCT02426099 · COMPLETED

Trial details

NCT number: NCT02426099
Sponsor: Sobngwi Eugene
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Hypertension, Resistant to Conventional Therapy Diabetes Mellitus

Start date: 2011-10-01
Primary completion: 2012-10-01
Enrollment: 17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.